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Background: Malignant liver tumors with osteoclast-like giant cells are rare. A literature search showed 17 previously
reported cases that included the following: (1) 8 undifferentiated hepatocellular carcinomas, (2) 5 sarcomatous tumors
with osteoclast-like giant cells associated with intrahepatic cholangiocarcinoma or liver cystadenocarcinoma, and (3) 4
sarcomatoid tumors with osteoclast-like giant cells associated with areas of a conventional hepatocellular carcinoma.
Case presentation: A 68-year-old man presented with a tumor of the right lobe of the liver on ultrasonography and
computed tomography. Laparoscopy showed a tumor (diameter, 4 cm) in segments 7 and 8 of the right liver lobe that
adhered to the retroperitoneum. The tumor recurred 3 months after liver segmentectomy. Repeat laparoscopy showed
diffuse and nodular metastases to the omentum and peritoneum.
Result: Light microscopy showed that part of the tumor had features of classic hepatocellular carcinoma. Another part of
the tumor had a solid sarcomatous pattern with osteoclast-like giant cells that were irregularly distributed between the
smaller undifferentiated tumor cells; cells of this part of the tumor were positive for heppar-1.
Conclusion: Light microscopic findings including osteoclast-like giant cells, and the strong reaction of heppar-1 antibody
with cells of the sarcomatous part of the tumor, confirmed that this sarcomatous element was a metaplastic or
transformed portion of hepatocellular carcinoma.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.
eu/vs/6000512901462616
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Malignant liver tumors with osteoclast-like giant cells are
extremely rare. Since this entity was described in 1980, a
total of 17 cases have been reported. In 8 of these tumors,
histology showed similarities to giant cell tumor of bone,
including multiple osteoclast-like giant cells and proliferat-
ing malignant undifferentiated mononuclear cells [1-8].
The clinical appearance of these tumors might be con-
sistent with an unusual variant of hepatocellular carcin-
oma. According to the World Health Organization
classification of tumors of the digestive system, these
tumors might be classified as undifferentiated carcin-
omas of the liver [9]. In 5 of the 17 tumors, the sar-
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unless otherwise stated.associated with intrahepatic cholangiocarcinomas or
cystadenocarcinomas of the liver [10-14]. Only 4 of the
17 tumors that have been reported could be classified as
sarcomatoid hepatocellular carcinomas with osteoclast-like
giant cells, according to the World Health Organization
classification, because they comprised sarcomatoid tumors
with osteoclast-like giant cells and areas of classic hepato-
cellular carcinoma. In 2 of these 4 tumors, transitional fea-
tures were noted between the conventional hepatocellular
carcinoma and the sarcomatous portion of the tumor that
contained osteoclast-like giant cells [15-18].
The histogenesis of the sarcomatoid portion of these liver
tumors is controversial because of the similarity to giant
cell tumor of bone or other mesenchymal tumors that have
osteoclast-like giant cells. Literature search showed no pre-
vious reports of sarcomatoid hepatocellular carcinoma withan Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Multinodular tumor of the liver with central necrosis and
hemorrhage surrounded by normal liver tissue.
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could be described unequivocally as a transformed or meta-
plastic portion of classic liver cell carcinoma based on
morphology or additional immunohistochemical studies in-
cluding reactivity with heppar-1 antibody. We evaluated a
patient who had sarcomatoid hepatocellular carcinoma that
was associated with osteoclast-like giant cells.
Case presentation
Clinical evaluation
A 68-year-old man was suspected to have a tumor of the
right lobe of the liver based on ultrasonography that was
performed during a routine examination. A computed
tomography (CT) scan showed evidence of a malignant
liver neoplasm. The past medical history included insulin-
dependent type 2 diabetes mellitus and hypertension for
10 years. The patient had a long history of consuming 2 L
wine and cider daily. Laboratory findings showed slightly
increased levels of gamma-glutamyl transferase, liver
transaminases, carcinoembryonic antigen, and carbohy-
drate antigen 19–9. Antihepatitis B core and antihepatitis
C virus tests were negative. Laparoscopy showed a tumor
(diameter, 4 cm) in segments 7 and 8 of the right liver lobe
that adhered to the retroperitoneum. Biopsies of the
tumor and tumor-free liver tissue were sent for frozen sec-
tion analyses. Additional staging procedures were negative
for bone and lung metastases. The patient requested sur-
gery, and atypical segmentectomy of the liver was per-
formed 2 weeks later. Spiral CT scan of the abdomen
3 months later showed tumor recurrence in segment 6 of
the right lobe of the liver. The patient developed massive
ascites. Repeat laparoscopy showed diffuse and nodular
metastases to the omentum and peritoneum of the right
upper abdomen. Tumor biopsies were sent for frozen sec-
tion analysis. Palliative therapy was recommended.
Method
The tissue specimens were fixed in 10% formalin and
embedded in paraffin. Routine stains and immunostains
were performed on 4-μm sections. The following anti-
bodies were applied: antihuman hepatocyte (Heppar-1,
clone OCH1E5, 1:200, Dako Denmark, Glostrup, Denmark),
CD68 (clone KP1, 1:3000, Dako), acid phosphatase (clone
26E5, 1:50, Novocastra, Newcastle upon Tyne, UK),
and cytokeratin (AE1/AE3, 1:100, Zytomed Systems,
Berlin, Germany). The deparaffinized and rehydrated
sections were subjected to heat-induced epitope re-
trieval with citrate buffer (pH, 6.0) at a dilution of 1:10
(Zytomed) in an oven (96°C). Staining was performed
in an automated stainer (Dako Autostainer, Dako). A
streptavidin-biotin kit (ZytoChem-Plus HRP Kit, Broad
Spectrum, Zytomed) was used for detection and com-
bined with a 3,3′-diaminobenzidine tetrahydrochloride
chromogen (DAB substrate kit, Zytomed).Gross examination
At the first diagnostic laparoscopy, a wedge liver biopsy
was performed (8 × 5 × 3 mm) and additional smaller
pieces were excised. The atypical segmentectomy speci-
men (9 × 8 × 5 cm; 115 g) contained a tumor (largest
diameter, 6 cm) that was well demarcated and sur-
rounded by normal yellow and brown liver parenchyma.
The gray-white tumor included multiple confluent nod-
ules of various sizes and contained areas of fresh and old
hemorrhage and fibrosis (Figure 1).
Histology
The tumor-free parenchyma of the liver had marked
chronic periportal hepatitis and moderate fibrosis, re-
sidual features of alcoholic hepatitis that were noted in
the previous biopsy. There was no high-grade fibrosis or
cirrhosis of the liver. The first biopsy of the liver tumor
showed carcinoma with multiple osteoclast-like giant
cells (Figure 2). The possibility of a secondary tumor
could not be excluded.
Light microscopic examination showed that the tumor
in the atypical liver resection specimen was incompletely
encapsulated. It was composed of multiple nodules of
different sizes that were incompletely encapsulated by fi-
brous bands of varied thickness. The microscopic ap-
pearance of the tumor was highly varied in the different
nodules. Part of the tumor exhibited features of classic
hepatocellular carcinoma, and another part of the tumor
exhibited a solid sarcomatous pattern. The hepatocellu-
lar carcinoma contained a large variety of growth pat-
terns that included trabecular and pseudoglandular or
compact patterns. Most of the atypical hepatocytes of
these well-to-moderately-differentiated areas of the car-
cinoma had large, well-delineated granular eosinophilic
cytoplasm and moderately enlarged nuclei with promin-
ent nucleoli. In the less-well-differentiated areas, the
cells contained bizarre hyperchromatic giant nuclei. The
cytoplasm of numerous atypical hepatocytes contained
Figure 2 Sarcomatoid hepatocellular carcinoma with osteoclast-like
giant cells and a minimal epithelial component (hematoxylin-eosin,
original magnification × 200).
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porting connective tissue was inconspicuous in most
parts of the tumor. In a few areas, a scirrhous growth
pattern was noted with broad bands of hyalinized colla-
gen fibers along the sinusoids that resembled fibrolamel-
lar carcinoma (Figure 3). Additionally, there were sparse
areas of carcinoma with duct-like features that were
similar to bile duct proliferation in the adjacent scar
tissue.
The sarcomatous portion of the liver tumor included
polymorphous, spindle-shaped, or oval cells (small-to-
moderate size) with small, ill-defined clear cytoplasm.
The nuclei were round or spindle-shaped with overall
marked anaplasia. Blast-like cells had large vesicular nu-
clei and prominent nucleoli. Mitotic figures were noted
frequently. The spindle-shaped tumor cells occasionallyFigure 3 Scirrhous growth pattern of the hepatocellular carcinoma
that resembled a fibrolamellar carcinoma (hematoxylin-eosin, original
magnification × 200).formed broad fascicles that had the appearance of an un-
differentiated spindle cell sarcoma. In some nodules,
these spindle cell proliferations enclosed trabeculae of
atypical liver cells or tubular structures (Figure 4).
In the sarcomatous portion of the tumor, larger areas
were noted that had osteoclast-like giant cells that were
irregularly distributed between the smaller undifferenti-
ated tumor cells. In these areas, the tumor resembled
giant cell tumor of bone. The osteoclast-like giant cells
had a large eosinophilic cytoplasm and contained many
small round nuclei with small nucleoli. In a few of the
nodules, the tumor consisted of a mixture of osteoclast-
like giant cells and small syncytial complexes and tu-
bules of atypical epithelial cells. Both components of
these nodules appeared very similar and might have
been mixed with each other in the hematoxylin-eosin
stain. The metastatic tumor of the peritoneal biopsies
had essential features of the primary tumor including
osteoclast-like giant cells.Immunohistochemistry
The antibody heppar-1 strongly reacted with the tumor-
free liver tissue and the tumor cells of the well-to-
moderately-differentiated hepatocellular carcinoma. The
staining of the areas of the less-well-differentiated carcin-
oma with marked nuclear anaplasia was decreased or
patchy. The sarcomatous portion of liver tumor was almost
completely negative for heppar-1 and cytokeratin AE1/AE3.
The osteoclast-like giant cells and small mononuclear
histiocytic cells of the tumor stroma were positive for the
histiocytic markers CD68 and acid phosphatase (Figure 5)
and were cytokeratin AE1/AE3-negative. The sparse areas
with duct-like features were positive for cytokeratin AE1/
AE3 and focally positive for heppar-1.Figure 4 Sarcomatoid hepatocellular carcinoma with features of a
spindle-cell sarcoma and a minimal epithelial component
(hematoxylin-eosin, original magnification × 200).
Figure 5 CD68 staining of the osteoclast-like giant cells distributed
among atypical mononuclear undifferentiated cells and epithelial
cells (original magnification × 200).
Figure 6 The heppar-1 stain marked the preserved isolated atypical
hepatocytes and tubules in the sarcomatoid stroma (original
magnification × 200).
Figure 7 Isolated heppar-1-positive tumor cell bordering an
osteoclast-like giant cell (original magnification × 400).
Dahm Diagnostic Pathology  (2015) 10:40 Page 4 of 7The tumor area with the scirrhous pattern was CD68-
negative. In the areas in which the osteoclast-like giant
cells and epithelial cell complexes were intensely mixed,
the CD68 stain (unlike the hematoxylin-eosin stain) dis-
tinguished the 2 cell types; the epithelial tumor cells
remained unstained and were marked only by the coun-
terstain. However, a few malignant epithelial cell prolifera-
tions in these areas were positive for heppar-1 and AE1/
AE3. The classic hepatocellular carcinoma and the area of
sarcomatous growth exhibited occasional areas of conflu-
ence. In the other areas, the epithelial tumor was infil-
trated or destroyed by sarcomatous tumor growth. The
close contact of tissue with both growth patterns mim-
icked transformation of the epithelial tumor to a sarcoma-
tous growth pattern. However, the full appearance of
transformation became visible at higher magnification in
other areas in which the trabeculae of the atypical hepato-
cytes of the conventional hepatocellular carcinoma (which
exhibited large eosinophilic cytoplasm and marked nu-
clear anaplasia) transformed into strands and nests of
smaller cells (that exhibited ill-defined clear cytoplasm).
The atypical liver cells acquired the characteristics of
the surrounding sarcomatous tumor cells but occasion-
ally could be diagnosed as hepatocytes because of their
Mallory body content. This impression was supported
by findings of strongly positive heppar-1 staining in the
single epithelial cells and trabeculae or small tubules of
the epithelial tumor cells within the sarcomatous tumor
tissue (Figure 6). Very rarely, heppar-1-positive single
epithelial tumor cells were observed in close contact
with the osteoclast-like giant cells (Figure 7).
Discussion
This 68-year-old man in whom a liver tumor was noted
on ultrasonography and CT scan received a diagnosis ofcarcinoma with osteoclast-like giant cells based on ana-
lyses of laparoscopic frozen sections. The atypical liver
resection specimen contained a tumor (diameter, 6 cm),
and there were no signs of cirrhosis in the tumor-free
liver tissue. Histologic evaluation of the liver tumor
showed 2 parts that included conventional hepatocellu-
lar carcinoma and a sarcomatous tumor with multiple
osteoclast-like giant cells. The hepatocellular carcinoma
had multiple growth patterns that included trabecular,
pseudoglandular, and compact patterns. A few areas had
the tubular features that can occur in 5% to 10% tra-
becular liver cell carcinomas [11].
The fibrotic areas of the tumor also had the appear-
ance of fibrolamellar carcinoma; however, fibrolamellar
carcinomas are CD68-positive [19], and the fibrotic area
in the present tumor was CD68-negative. Therefore, the
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growth pattern of hepatocellular carcinoma [20].
The transformation of classic liver cell carcinoma to
the sarcomatous tumor was observed at higher magnifi-
cation with hematoxylin-eosin stain where the trabecu-
lae of the atypical hepatocytes blended into strands and
nests of small tumor cells. These small tumor cells had
ill-defined clear cytoplasm, and became indistinguishable
from the cells of the surrounding sarcomatous tumor
tissue by light microscopy. These undifferentiated cells
occasionally contained Mallory bodies, which is consist-
ent with a tumor of liver cell origin. The strongly posi-
tive heppar-1 staining of the single cells and trabeculae
of the epithelial cells and tubules in the sarcomatous
component of the liver tumor provided further evidence
of transformation of conventional hepatocellular carcin-
oma into a sarcomatous tumor. The transition of trabecu-
lar hepatocellular carcinoma to spindle cell hepatocellular
carcinoma has been well documented for sarcomatoid he-
patocellular carcinomas [11]. However, we were unable to
find any previous reports that confirmed this transition in
a sarcomatoid hepatocellular carcinoma with osteoclast-
like giant cells by immunohistochemical methods.
A literature search identified 17 previously reported
liver tumors with osteoclast-like giant cells that resem-
bled an osteoclastoma or giant cell tumor of bone. There
were 3 histologic types in these previously reported tu-
mors: (1) undifferentiated tumors (8 tumors) that were
not associated with conventional carcinomas, (2) sar-
comatous tumors (5 tumors) that were associated with a
cholangiocarcinoma or cystadenocarcinoma of the liver,
and (3) sarcomatous tumors that were associated with clas-
sic hepatocellular carcinomas (4 tumors), as observed in
the present patient.
The first osteoclastoma-like giant cell tumor of the
liver with a tumor stroma of malignant mononuclear
cells with polygonal or spindle-shaped nuclei was de-
scribed in 1980 [6]. Numerous osteoclast-like giant cells
were distributed among the pleomorphic mononuclear
cells. The absence of hepatocellular carcinomatous fea-
tures was noted. A transition of the hepatocytes to
tumor cells from the disrupted hepatic cell plates was
not observed. There were no ultrastructural features that
indicated an epithelial or hepatocellular origin of the
malignant mononuclear cells. However, the presentation,
clinical course, and gross pathology closely resembled
hepatocellular carcinoma [6].
Another cellular liver tumor had 2 completely different
cell types (osteoclast-like giant cells and pleomorphic
mononuclear cells). Again, no histologic features typical
of hepatocellular carcinoma were observed. The tumor
was negative for keratin. Electron microscopic observa-
tion of desmosome-like junctions suggested the diagno-
sis of spindle cell carcinoma [2].The same results were observed in a third tumor of
the liver with similar features [3]. Another example of
this tumor type included mononuclear tumor cells that
stained strongly positive for alpha-fetoprotein and
weakly positive for anticytokeratin (CAM 5.2) [5]. The
osteoclast-like giant cells were strongly positive for
CD68 staining. No epithelial features were identified on
electron microscopy.
Another liver tumor contained no overt hepatocellular
carcinoma but exhibited features reminiscent of hepato-
cellular carcinoma in a small region that contained
round cohesive tumor cells in a vaguely trabecular pat-
tern [8]. A few malignant cells were positive for cytoker-
atins (CK7, CK8, and CK19). In another similar tumor,
no trabecular or lobular pattern was noted. The focal
positivity for CK19 and epithelial membrane antigens
supported the diagnosis of undifferentiated carcinoma of
the liver with an abundant osteoclast-like giant cell com-
ponent [1]. Another tumor that was diagnosed as an
osteoclast-like giant cell tumor of the liver contained
malignant cells that were immunohistochemically posi-
tive for alpha-1-antitrypsin and alpha-1-chymotrypsin
but negative for epithelial markers [7].
The origin of 1 carcinoma with osteoclast-like giant
cells was documented from the wall of a large cyst of
the liver [11]. This tumor was similar to a previously de-
scribed tumor [6], and might be included in the group of
cholangiocarcinomas. A sarcomatoid cholangiocellular
carcinoma with osteoclast-like giant cells has been de-
scribed with apparent tubule formations and predomin-
ant sarcomatous features. The spindle-shaped malignant
cells exhibited positive reactions to cytokeratin and
vimentin [12].
An osteoclast-like giant cell tumor of the liver that
was associated with atypical intraductal epithelial prolif-
erations was evaluated for mutations at codon 12 of the
K-ras oncogene to determine the relation between the
noninvasive epithelial proliferations and the infiltrating
tumor. The identical genetic findings suggested that the
osteoclast-like giant cell tumor of the liver was an undif-
ferentiated cholangiocarcinoma [14].
In another report, the authors described the associ-
ation of a mucoepidermoid variant of a cholangiocarci-
noma of the liver and an osteoclast-like giant cell tumor
[10]. Another liver tumor with osteoclast-like giant cells
presented as a thrombus in the inferior vena cava; this
tumor was diagnosed as an undifferentiated cholangio-
cellular carcinoma on the basis of strong positivity of the
tumor cells for CK19 and CK7 [13]. Similar findings
were described in tumors of type 1; therefore, although
the tumors of this type were interpreted as hepatocellu-
lar carcinomas, some of them might also have been un-
differentiated cholangiocarcinomas or this tumor might
be included in type 1.
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including the present tumor, are characterized by the
combined occurrence of conventional hepatocellular car-
cinoma and sarcomatous tumor with osteoclast-like
giant cells. In 1 of these tumors, 2 distinct areas included
a conventional hepatocellular carcinoma with a trabecu-
lar pattern and an osteoclast-like giant cell tumor, sepa-
rated by connective fibrous tissue [15].
A previously described and similar liver tumor exhib-
ited several microscopic fields, and < 5% of the tumor
had the histologic appearance of typical hepatocellular
carcinoma [16]. The diagnosis was hepatic giant cell car-
cinoma. This latter term was used by others to designate
primary liver tumors with either multinucleated or pleo-
morphic large cells [11,16]. Other workers have sug-
gested that the term giant cell carcinoma in this case
might be misleading and that the term liver cell carcin-
oma with osteoclast-like giant cells might be more accur-
ate [21]. In a third report, a multifocal primary liver
tumor was diagnosed as moderately differentiated hepato-
cellular carcinoma with a trabecular pattern in segment 4
and poorly differentiated hepatocellular carcinoma with a
sarcomatoid pattern with osteoclast-like giant cells in seg-
ments 7 and 8 [17]. The fourth reported tumor of this type
had 2 distinct components: a well-to-moderately differen-
tiated conventional hepatocellular carcinoma with tra-
becular and pseudoglandular growth patterns, and a tumor
with spindle-to-oval mononuclear cells and osteoclast-
like giant cells [18]. There were transitions between
both components in a single nodule. The 4 cited arti-
cles described liver tumors that had classic hepatocellu-
lar carcinomas and areas of sarcomatous tumors with
osteoclast-like giant cells [15-18]. The authors of 2 of
these cases concluded from the close proximity of the car-
cinomatous and sarcomatous tumor elements that the lat-
ter might have been a dedifferentiated part of the liver cell
carcinoma [17,18]. The present case provides additional
evidence for a transition from a carcinomatous to sar-
comatous tumor; based on hematoxylin-eosin staining
and immunohistochemical evaluation with heppar-1 anti-
body, the sarcomatous element of the liver tumor probably
was a metaplastic hepatocellular carcinoma. Tumors that
contain scattered multinucleated giant cells comparable to
normal osteoclasts have been described in varied sites in-
cluding the thyroid, lung, breast, pancreas, and salivary
glands [21]. They mostly are interpreted as rare neoplasms
composed of highly pleomorphic neoplastic mononuclear
cells and large, nonneoplastic multinucleated, histiocytic
giant cells [22]. This interpretation was favored in most ar-
ticles about liver tumors discussed above, on the basis of
the histologic and immunohistochemical findings. How-
ever, in 1 case, both the osteoclast-like giant cells and
mononuclear cells were considered mesenchymal in origin
[6]. In another liver tumor, both mononuclear and giantcells showed ultrastructural features typical of hepatocel-
lular carcinoma [16].
The nonneoplastic multinucleated giant cells are termed
osteoclast-like because of their resemblance to osteoclasts.
On scanning electron microscopy, the 2 cell types are in-
distinguishable. They also share some features by trans-
mission electron microscopy, but the osteoclast-like cells
lack the characteristic complex ruffled border of the
osteoclast. The subplasmalemmal accumulation of polyri-
bosomes and cisternae of the rough endoplasmic reticulum
of the osteoclast-like cells marks them as histiocytic cells.
In tissue culture, the osteoclast-like cells can resorb bone,
similar to osteoclasts. This suggests that this function of
these macrophage-derived cells is induced by local factors,
which also may explain giant cell formation [23]. Therefore,
this type of carcinoma may have the capacity to induce
nonneoplastic, osteoclast-like elements within themselves
[21]. At present, the occurrence of these osteoclast-like
giant cells in very few carcinomas at different sites remains
an enigma.
Conclusion
The present sarcomatoid hepatocellular carcinoma with
osteoclast-like giant cells is a rare tumor of the liver,
and only 4 other comparable cases have been described
previously. These tumors have areas of classic liver cell car-
cinoma and a sarcomatous tumor with multiple osteoclast-
like giant cells. The liver cell carcinoma portion of the
present tumor was remarkable because it combined several
rare growth patterns. Additionally, the transformation from
epithelial to mesenchymal tumor was shown with routine
stains and immunohistochemical evaluation, and this con-
firmed that the sarcomatous portion of the tumor with
osteoclast-like giant cells represented the metaplastic part
of the hepatocellular carcinoma. Analogous features might
be observed in similar tumors from different sites.
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